Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heme polymerase in *Plasmodium falciparum* refers to the molecular machinery responsible for converting toxic free heme, released during hemoglobin digestion, into an inert crystalline pigment called hemozoin. This process is essential for parasite survival within red blood cells and is a validated target for antimalarial drug development. While Histidine-rich protein II (HRPII) is implicated as a key mediator, the exact molecular identity of the polymerase remains under investigation. Lipids may also contribute to the process.
Inhibition of hemozoin formation, leading to toxic heme accumulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme Polymerase (Plasmodium falciparum) (HP).